About
Judy Chou, Ph.D., is the President, CEO, and board member of AltruBio, a clinical-stage biotechnology company focused on immunological and inflammatory diseases. She previously led Bayer Pharmaceuticals' global biotech organization and earlier held senior roles at Pfizer/Medivation and Tanvex Biopharma. She also serves on the board of Akero Therapeutics and on the governing board of the California Institute for Regenerative Medicine.
Areas of interest
biotechimmunologyinflammationbiomanufacturingdrug developmentregenerative medicinecell and gene therapy